We welcome the announcement today by Minister for Health and Aged Care Mark Butler of Genomics Australia, a national body to provide leadership, coordination and expertise so all Australians can reap the benefits of cutting-edge genomic research and technologies. The announcement said one of Genomics Australia's first priorities will be to improve access to personalised cancer care. The Blood Cancer Research Roadmap—released earlier this week with a goal of zero preventable deaths by 2035—listed personalised medicine as one of three missions, calling for the integration of advanced genomics into models of care. View the roadmap: https://lnkd.in/gJfN3Y22 Government announcement: https://lnkd.in/gCr9cV9m Australian Government Department of Health and Aged Care #genomics
The Australian Academy of Science’s Post
More Relevant Posts
-
🗣️ BGI Genomics 2024 Global Colorectal Cancer Awareness Report is out now! 🌍 +1900 respondents. 6 countries covered. • Brazil • China • Poland • Saudi Arabia • Thailand • Uruguay Some key findings: • #CRCScreening gaps vary globally • Preference for fecal testing over colonoscopy • Cost and fear are screening barriers • Medical advice and family history trigger screening Dr. Zhu Shida, BGI Genomics Deputy GM, notes: “Colonoscopy remains the gold standard, but innovative, #accessible testing is crucial for #EarlyDetection." Let's bridge the gap and transform CRC from a life-threatening disease to a manageable condition. 📈 Read full insights at: https://lnkd.in/d9pmrjg9 Follow us for more daily health-related content! #ColorectalCancer #CRCAwareness #PublicHealth #BGIGeneTest
-
-
AI is so much more than just chat bots and virtual assistants, here is an example of how AI can improve our lives in a meaningful way. #IamCerebras #ai #ml
📢 Cerebras and Mayo Clinic are proud to announce a new state-of-the-art foundation model for genomics. The model achieves unprecedented accuracy in disease prediction: 87% for Rheumatoid Arthritis, 96% for cancer predisposition, and 83% for cardiovascular conditions. The breakthrough was made possible by combining Mayo Clinic's extensive patient data with the Cerebras AI platform, training on over a trillion tokens to create complex genomic models that can guide personalized treatment decisions. Presented at the 2025 JPMorganChase Healthcare Conference. Read more: https://cerebras.ai/mayo #Healthcare #AI #Genomics #PrecisionMedicine #JPM2025
Stay connected
-
Early detection of cancer leads to better clinical outcomes, but current screening programmes are limited. Researchers have used Danish health registry data to develop a statistical model that can predict an individual’s risk of developing cancer, based on their family history, disease history, and lifestyle. This work shows that health registries can be used to identify individuals who are at high risk of developing different cancer types. In the long run, such models could potentially guide cancer screening programmes to enable earlier detection. https://lnkd.in/entH4WRW #cancerresearch #cancerscreening #statistics #bioinformatics DKFZ German Cancer Research Center Københavns Universitet - University of Copenhagen UK Biobank Ewan Birney
-
📢 Cerebras and Mayo Clinic are proud to announce a new state-of-the-art foundation model for genomics. The model achieves unprecedented accuracy in disease prediction: 87% for Rheumatoid Arthritis, 96% for cancer predisposition, and 83% for cardiovascular conditions. The breakthrough was made possible by combining Mayo Clinic's extensive patient data with the Cerebras AI platform, training on over a trillion tokens to create complex genomic models that can guide personalized treatment decisions. Presented at the 2025 JPMorganChase Healthcare Conference. Read more: https://cerebras.ai/mayo #Healthcare #AI #Genomics #PrecisionMedicine #JPM2025
Stay connected
-
Proud to announce the Mayo Genomic AI Foundation Model built by Cerebras Systems and Mayo Clinic at the J.P. Morgan Healthcare Conference today. This represents the fruit of deep collaboration between world-leading teams of ML experts, medical domain experts, and Mayo Clinic data. Together, our partnership is delivering better diagnostics and predictions for Rheumatoid Arthritis, Cancer, and Heart Disease. Extremely impactful work to launch 2025. Follow Cerebras on LinkedIn: https://lnkd.in/gYvgxAEk #AI #JPMHealth #Healthcare #Cerebras
📢 Cerebras and Mayo Clinic are proud to announce a new state-of-the-art foundation model for genomics. The model achieves unprecedented accuracy in disease prediction: 87% for Rheumatoid Arthritis, 96% for cancer predisposition, and 83% for cardiovascular conditions. The breakthrough was made possible by combining Mayo Clinic's extensive patient data with the Cerebras AI platform, training on over a trillion tokens to create complex genomic models that can guide personalized treatment decisions. Presented at the 2025 JPMorganChase Healthcare Conference. Read more: https://cerebras.ai/mayo #Healthcare #AI #Genomics #PrecisionMedicine #JPM2025
Stay connected
-
Exactly why I love to be at the bridge of conventional healthcare and AI powered tech. A lot of advantages for healthcare systems to exploit and upskill the workforce for more value added activities. Congrats to the Product and AI teams and CHSC for successfully deploying this!!
M42's Capital Health Screening Centre (CHSC) has significantly advanced diagnostic capabilities, now performing up to 2,000 AI-assisted chest X-rays daily—a 10-fold increase over conventional methods. Using AIRIS-TB technology, CHSC is enhancing tuberculosis (TB) detection with a remarkable sensitivity of 99.73%, exceeding WHO’s threshold. This AI-driven solution also holds the potential to identify additional conditions such as lung cancer, pneumonia, and emphysema, streamlining the diagnostic process for more efficient interventions. #AI #Innovation #AIHealth
-
🚨New Article Alert! 🚨 Unraveling the Intricate Nexus: "Diabetes and Cancer — Two Epidemic Diseases Requiring an Opposite Therapeutic Approach to Target Cells" 🩺🔍 Our latest publication dives deep into the paradoxical treatment strategies needed for these twin epidemics. Discover how managing one can impact the other and the fine balance scientists strive for in therapy. 👉 Click the link or scan the QR code in the comments to read, download, and share this groundbreaking exploration. Spread the knowledge and fuel crucial conversations in medical science! 💡🌐 https://lnkd.in/gQPsSH_q #DiabetesAndCancer #EpidemicDiseases #TherapeuticParadox #MedicalResearch #ShareTheScience
-
-
Head of Healthcare & Federated Data Solutions Expert | Driving secure, scalable platforms to empower researchers and accelerate precision medicine advancements
Thrilled to share Lifebit’s partnership with the Psifas Initiative for Precision Medicine, advancing one of the largest precision medicine efforts in the Middle East. Together, we’re enabling secure genomic research to drive breakthroughs in cancer, diabetes, and cardiovascular health. Excited for what’s ahead! #precisionmedicine #federation #genomics
🌍 Exciting Partnership Announcement! Lifebit is proud to partner with Psifas Initiative for Precision Medicine, Israel's leading Genomic Medicine Initiative, to revolutionize genomic research and advance personalized medicine. By leveraging Lifebit’s Trusted Research Environment (TRE), this collaboration will securely manage and analyze clinical-genomic data from Israel’s diverse population, enabling breakthroughs in diseases like cancer, diabetes, and cardiovascular conditions. Read the full story here: 👉 https://bit.ly/4jpJKFs Together, we’re shaping the future of healthcare innovation! 🚀 #Genomics #PrecisionMedicine #TRE #Innovation
-
-
Researchers at The Chinese University of Hong Kong and Yale School of Medicine conducted a meta-analysis to investigate the relationship between gut microbiota and immune checkpoint inhibitors https://lnkd.in/ekst2FCd They found that trans-kingdom gut microbiota, including bacteria and eukaryotes, differed significantly between ICI responders and non-responders across multiple cancer types. Specific microbial species, such as Faecalibacterium prausnitzii and Nemania serpens, were consistently enriched in responders and showed promise in predicting ICI response. These responder-enriched species were also found to modulate CD8+ T cell activity, highlighting their potential role in enhancing immunotherapy outcomes. Yufeng Lin ∙ Mingxu Xie ∙ Harry Cheuk-Hay Lau ∙ Ruijie Zeng ∙ Ruyi ZHANG ∙ Luyao Wang ∙ Qing Li ∙ Yiwei Wang ∙ danyu Chen ∙ Lanping Jiang ∙ William Damsky, MD, PhD ∙ Jun Yu #GutMicrobiota #ImmuneCheckpointInhibitors #ICIResponse #FaecalibacteriumPrausnitzii #NemaniaSerpens #CancerImmunotherapy #MicrobialBiomarkers
-
-
🌟 Exciting advancements are taking place at m42's Capital Health Screening Center (CHSC) ! The recent integration of #AI-assisted diagnostic capabilities is a significant leap forward in healthcare technology. With the ability to perform up to 2,000 chest X-rays daily—representing a remarkable 10-fold increase over traditional methods—CHSC is setting a new standard in rapid and accurate diagnostics. Utilizing AIRIS-TB technology, the Centre has achieved an impressive sensitivity of 99.73% in tuberculosis detection, well above the World Health Organization’s threshold. This innovative AI-driven solution not only excels in TB detection but also shows promise in identifying other critical conditions such as lung cancer, pneumonia, and emphysema. By streamlining the diagnostic process, CHSC is paving the way for more efficient interventions, ultimately improving patient outcomes and enhancing overall public health. Such initiatives exemplify the transformative potential of AI in healthcare and underline the importance of ongoing investment in cutting-edge technologies. I commend CHSC for prioritizing innovative solutions that will undoubtedly shape the future of medical diagnostics. Emirates Medical Association Radiology society of the Emirates(RSE) #HealthcareInnovation #AIDiagnostics #Tuberculosis #PublicHealth #PatientCare #HealthTech #MedicalImaging #LungHealth
M42's Capital Health Screening Centre (CHSC) has significantly advanced diagnostic capabilities, now performing up to 2,000 AI-assisted chest X-rays daily—a 10-fold increase over conventional methods. Using AIRIS-TB technology, CHSC is enhancing tuberculosis (TB) detection with a remarkable sensitivity of 99.73%, exceeding WHO’s threshold. This AI-driven solution also holds the potential to identify additional conditions such as lung cancer, pneumonia, and emphysema, streamlining the diagnostic process for more efficient interventions. #AI #Innovation #AIHealth
